Literature DB >> 36094664

Diagnostic values of plasma matrix metalloproteinase-7, interleukin-8, and gamma-glutamyl transferase in biliary atresia.

Bo Wu1, Ying Zhou2, Xinbei Tian1, Wei Cai3,4,5,6, Yongtao Xiao7,8,9,10.   

Abstract

Biliary atresia (BA) is a severe cholestatic liver disease in children featuring cholestasis and liver fibrosis. The early diagnosis of BA is still challenging. This study aimed to evaluate the diagnostic values of matrix metalloprotease-7 (MMP-7), interleukin-8 (IL-8), and gamma-glutamyl transferase (GGT) in BA. Infants diagnosed with BA and non-BA between 2013 and 2018 were retrospectively analyzed. Plasma levels of MMP-7, IL-8, and GGT were measured in these infants. The receiver operating characteristic (ROC) curves and area under the ROC curve (AUC) were used to assess the diagnostic values of MMP-7, IL-8, and GGT. The expression of MMP-7 and IL-8 in the livers was detected by immunofluorescence staining. A total of 229 infants were enrolled in this study: 156 BA infants and 73 non-BA infants including 16 ones with infantile hepatitis syndrome. The plasma levels of MMP-7, IL-8, and GGT in BA infants had a median of 11.8 ng/mL (interquartile range, IQR: 5.3-57.5), 1.5 ng/mL (IQR: 1.0-2.8), and 381.0 U/L (IQR: 197.0-749.0), respectively, which were higher than non-BA subjects [MMP-7, 4.4 ng/mL (IQR: 3.3-6.1); IL-8, 0.7 ng/mL (IQR: 0.5-1.0); GGT, 59.0 U/L (IQR: 26.0-124.0)]. The AUC values of MMP-7, IL-8, and GGT for the diagnosis of BA were 0.8035, 0.8083, and 0.9126, respectively. The AUC values of MMP-7 + IL-8, MMP-7 + GGT, IL-8 + GGT, and MMP-7 + IL-8 + GGT for the diagnosis of BA were 0.8248, 0.9382, 0.9168, and 0.9392, respectively. The AUC values of MMP-7, IL-8, and GGT for differentiating BA infants with cholic stool from non-BA infants with cholic stool were 0.8006, 0.8258, and 0.9141, respectively. The expression of MMP-7 and IL-8 was increased in the cholangiocytes in BA livers.   
Conclusion: Plasma MMP-7, IL-8, and GGT alone or a combination of them has good accuracy to differentiate BA from non-BA and may be reliable biomarkers for BA. What is Known: • Biliary atresia (BA) is a severe cholestatic liver disease in children featuring cholestasis and progressive liver fibrosis. • Although early diagnosis of BA is crucial for good outcomes, it remains a clinical challenge. What is New: • Plasma MMP-7, IL-8, and GGT alone or a combination of them has good accuracy to differentiate BA from non-BA. • Plasma MMP-7, IL-8, and GGT have good accuracy for differentiating BA infants with cholic stool from non-BA infants with cholic stool.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Biliary atresia; Gamma-glutamyl transferase; Interleukin-8; Matrix metalloprotease-7

Mesh:

Substances:

Year:  2022        PMID: 36094664     DOI: 10.1007/s00431-022-04612-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.860


  24 in total

1.  Newborn Screening for Biliary Atresia.

Authors:  Kasper S Wang
Journal:  Pediatrics       Date:  2015-12       Impact factor: 7.124

Review 2.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

3.  Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia.

Authors:  Chatmanee Lertudomphonwanit; Reena Mourya; Lin Fei; Yue Zhang; Sridevi Gutta; Li Yang; Kevin E Bove; Pranavkumar Shivakumar; Jorge A Bezerra
Journal:  Sci Transl Med       Date:  2017-11-22       Impact factor: 17.956

4.  Serum MMP-7 in the Diagnosis of Biliary Atresia.

Authors:  Jingying Jiang; Junfeng Wang; Zhen Shen; Xuexin Lu; Gong Chen; Yanlei Huang; Rui Dong; Shan Zheng
Journal:  Pediatrics       Date:  2019-10-11       Impact factor: 7.124

5.  Evaluation of matrix metalloproteinases and their endogenous tissue inhibitors in biliary atresia-associated liver fibrosis.

Authors:  Chih-Sung Hsieh; Jiin-Haur Chuang; Chao-Cheng Huang; Ming-Huei Chou; Chia-Lin Wu; Shin-Yi Lee; Chao-Long Chen
Journal:  J Pediatr Surg       Date:  2005-10       Impact factor: 2.545

6.  Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening.

Authors:  Marie-Odile Serinet; Barbara E Wildhaber; Pierre Broué; Alain Lachaux; Jacques Sarles; Emmanuel Jacquemin; Frédéric Gauthier; Christophe Chardot
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

Review 7.  Biliary atresia.

Authors:  Jane L Hartley; Mark Davenport; Deirdre A Kelly
Journal:  Lancet       Date:  2009-11-14       Impact factor: 79.321

Review 8.  Innate Immunity and Pathogenesis of Biliary Atresia.

Authors:  Ana Ortiz-Perez; Bryan Donnelly; Haley Temple; Greg Tiao; Ruchi Bansal; Sujit Kumar Mohanty
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

9.  Unique Cholangiocyte-Targeted IgM Autoantibodies Correlate With Poor Outcome in Biliary Atresia.

Authors:  Yuhuan Luo; Dania Brigham; Joseph Bednarek; Richard Torres; Dong Wang; Sara Ahmad; Cara L Mack
Journal:  Hepatology       Date:  2021-04-27       Impact factor: 17.425

10.  Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.

Authors:  Anna Kerola; Hanna Lampela; Jouko Lohi; Päivi Heikkilä; Annika Mutanen; Jaana Hagström; Taina Tervahartiala; Timo Sorsa; Caj Haglund; Hannu Jalanko; Mikko P Pakarinen
Journal:  J Pathol Clin Res       Date:  2016-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.